Stock screener

HRMY

Conviction 72HealthcareScan · Mon, Aug 10, 2026
HRMY$38.99+1.51%
ResistanceSupportVol 14
63 bars
Vol MA14 856.54K
May 11May 28Jun 16Jul 6Jul 23Aug 10
Harmony Biosciences Holdings, Inc.PHARMACEUTICAL PREPARATIONSwww.harmonybiosciences.com
Price38.99
Change+1.51%
Gap+0.53%
Rel volume0.61×
Avg volume956.4K
Avg $ vol34.61M
SMA 2036.04
SMA 5035.19
SMA 20033.40
Price vs 50+10.79%
Price vs 200+16.74%
MA stackbullish
50/200 cross
Supertrendup · 34.28
RSI (14)63
MACD hist0.30
MACD crossbull · 4d
Stoch %K / %D83 / 81
ADX (14)26
+DI / −DI29 / 11
RSI divergence
MACD divergence
ATR %+3.87%
ADR %4.16%
52w high40.51
52w low25.90
From 52w high-3.75%
Above 52w low+50.54%
New 52w highNo
SqueezeOff
Bollinger width18.95%
%B0.93
Donchian pos87.42%
Donchian high39.96
Donchian low32.25
AVWAP (52w high)32.92
vs AVWAP high+18.42%
AVWAP (52w low)32.92
vs AVWAP low+18.43%
OBV trendFlat
Chaikin MF (20)0.13
Today vs 20d0.61×
Avg vol (14d)856.54K
Avg vol (20d)956.4K
Avg $ vol (20d)34.61M
Market cap2.27B
RS 3m (vs SPY)+16.55%
RS 6m (vs SPY)-8.62%
RS line new highNo
Trend template6/8
Technical rank74.9
1 week+9.52%
1 month+5.84%
3 months+25.81%
6 months+4.61%
1 year+14.04%
YTD+4.31%
P/E14.31
P/B2.27
P/S2.61
P/FCF6.53
EPS2.71
Div yield
ROE15.88%
ROA11.56%
Debt/Eq0.15
Current3.48
EV/EBITDA
Gross margin77.16%
Net margin18.27%
Rev growth21.51%
EPS growth9.07%
Price target41.63
Target upside6.77%
Analyst ratingBuy
Institutional102.58%
Ent. value1.87B
Revenue261.28M
Net income75.43M
Gross profit198.08M
Free cash flow347.89M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out57.89M
Employees293
ListedWed, Aug 19, 2020
Free float47.26M
Float %82.1%
Short interest5.11M
Days to cover6.8d
Short volume67.8%
Squeeze score65 / 100
Next earnings
EPS forecast
Last EPS vs est$1.28 vs $0.97
Last surprise+32.0% beat
Setup gradeB
Conviction72 / 100
Pattern quality
Tech rank74.9 / 100
Group rank86 / 100 · Leading
Status laneNo active setup
Setup direction
Pattern family
Resistance39.43
Support32.66
Days since event
Candle confirm
News sentiment

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in HRMY

All disclosures →
No recent disclosed trades by Congress in HRMY. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in HRMY · 8 buys · 2 sells

InsiderSideShares
Graf R. Mark
Director · Stock Option · 2026-05-14
Grant21.87K
Germano Geno J
Director · Stock Option · 2026-05-14
Grant21.23K
Szyper Linda M
Director · Stock Option · 2026-05-14
Grant21.87K
Philip Ron M
Director · Stock Option · 2026-05-14
Grant21.87K
Sender Gary
Director · Stock Option · 2026-05-14
Grant21.87K
Sabater Juan A.
Director · Stock Option · 2026-05-14
Grant21.87K
Budur Kumar
CHIEF MEDICAL OFFICER · Restricted Stock Units · 2026-05-01
Exercise18.75K
Budur Kumar
CHIEF MEDICAL OFFICER · Common Stock · 2026-05-01
Exercise18.75K
Budur Kumar
CHIEF MEDICAL OFFICER · Common Stock · 2026-05-01
Tax8.88K
Reicin Glenn
CHIEF FINANCIAL OFFICER · Stock Option · 2026-04-14
Grant164.31K

SEC filings

EDGAR filings in HRMY · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.